* Advanced Polymer Systems Inc., Redwood City, Calif., hiredThomas Bigger as senior vice president responsible for the ethicalpharmaceutical business.* Alza Corp., Palo Alto, Calif., promoted Samuel Saks to senior vicepresident, medical affairs; promoted Gary Fulscher to senior vicepresident, operations; appointed Michael Paulik as vice president ofmanufacturing operations; promoted Ron Haak to vice president,technology development; and promoted Suzanne Martin to vicepresident, development programs.* AutoImmune Inc., Lexington, Mass., appointed Jo Ann Wallace tothe new position of vice president, corporate development.* BioSource International Inc., which has moved to Camarillo,Calif., named Anna Anderson vice president and chief financialofficer, and Richard Buford vice president of human resources.* Cephalon Corp., West Chester, Pa., appointed Joseph Day assenior vice president, worldwide corporate development; RichardCivil as senior medical director of North American clinicaloperations; and Richard Burgoon Jr. as senior director and patentcounsel.* ImmunoGen Inc., Cambridge, Mass., promoted Walter Blattler tosenior vice president, research and development; and John Lambertto vice president, research.* Incyte Pharmaceuticals Inc., Palo Alto, Calif., appointed BarryBloom to its board of directors.* Organogenesis Inc., Canton, Mass., hired Dale DeVore asmanaging director of the newly created Biomaterials Division.* Therexsys Ltd., London, appointed Peter Harris as medicaldirector, and Nowell Stebbing to its board of directors.* Trinity Biotech plc, Dublin, Ireland, added Donald Johnson andBrendan Farrell to its board of directors.* Verigen Inc., of Hopkinton, Mass., named Richard Strain aspresident and CEO. He had been with Eli Lilly & Co. for 24 years.* Vertex Pharmaceuticals Inc., Cambridge, Mass., promoted VickiSato to senior vice president, research and development; and hiredLynne Brum as director of corporate communications.

(c) 1997 American Health Consultants. All rights reserved.